These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 9528746)

  • 1. No primary prevention by pravastatin.
    Meyer FP
    Am J Med; 1998 Feb; 104(2):212-3. PubMed ID: 9528746
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevention of coronary heart disease with pravastatin.
    Samani NJ; de Bono DP
    N Engl J Med; 1996 May; 334(20):1333-4; author reply 1334-5. PubMed ID: 8609957
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of pravastatin on coronary events after myocardial infarction.
    Auerbach I; Behar S; Motro M
    N Engl J Med; 1997 Mar; 336(13):962. PubMed ID: 9072702
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of pravastatin on coronary events after myocardial infarction.
    Hazzard WR; Ettinger WH
    N Engl J Med; 1997 Mar; 336(13):961; author reply 962. PubMed ID: 9072700
    [No Abstract]   [Full Text] [Related]  

  • 5. Cholesterol reduction and coronary prevention.
    Prabhakaran D
    Natl Med J India; 1997; 10(1):24-5. PubMed ID: 9069704
    [No Abstract]   [Full Text] [Related]  

  • 6. Economic benefit analysis of primary prevention with pravastatin. Assumptions are methodologically flawed.
    Freemantle N; Mason J
    BMJ; 1998 Apr; 316(7139):1241-2. PubMed ID: 9583930
    [No Abstract]   [Full Text] [Related]  

  • 7. Prevention of coronary heart disease with pravastatin.
    Rogers S
    N Engl J Med; 1996 May; 334(20):1333; author reply 1334-5. PubMed ID: 8609956
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevention of coronary heart disease with pravastatin.
    Davis DR
    N Engl J Med; 1996 May; 334(20):1334; author reply 1335. PubMed ID: 8609958
    [No Abstract]   [Full Text] [Related]  

  • 9. Economic benefit analysis of primary prevention with pravastatin. Modelling economic benefits after such long term treatment is inappropriate.
    Pharoah P
    BMJ; 1998 Apr; 316(7139):1241-2. PubMed ID: 9553009
    [No Abstract]   [Full Text] [Related]  

  • 10. Primary prevention of coronary artery disease.
    Domanski MJ
    N Engl J Med; 2007 Oct; 357(15):1543-5. PubMed ID: 17928603
    [No Abstract]   [Full Text] [Related]  

  • 11. Overlap analysis of the West of Scotland coronary prevention study (WOSCOPS).
    Lim PO; Yee KM
    Circulation; 1999 Aug; 100(6):686. PubMed ID: 10441109
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pravastatin: pharmacological action, pleiotropic effects and efficacy in prevention of atherosclerosis].
    Bubnova MG; Aronov DM
    Kardiologiia; 2002; 42(7):88-95. PubMed ID: 12494119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Coronary mortality lowered by 24%. Convincing results of the LIPID Study on Secondary Prevention].
    Z Kardiol; 1998 Apr; 87(4 Suppl Uberzeugen):1-3. PubMed ID: 9618895
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term follow-up of the West of Scotland Coronary Prevention Study.
    DeFilippis AP; Bansal S; Blumenthal RS
    N Engl J Med; 2008 Jan; 358(2):194; author reply 194-5. PubMed ID: 18193527
    [No Abstract]   [Full Text] [Related]  

  • 15. Cholesterol-lowering drugs for primary prevention? The WOSCOP Study.
    Muntoni S
    Pharmacol Res; 1997 Mar; 35(3):169-70. PubMed ID: 9229402
    [No Abstract]   [Full Text] [Related]  

  • 16. Resource management in prevention of coronary heart disease: optimising prescription of lipid-lowering drugs.
    Shepherd J
    Lancet; 2002 Jun; 359(9325):2271-3. PubMed ID: 12103306
    [No Abstract]   [Full Text] [Related]  

  • 17. [LIPID study [Long-term Intervention with Pravastatin in Ischaemic Disease study]].
    Homma Y
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():416-21. PubMed ID: 11347106
    [No Abstract]   [Full Text] [Related]  

  • 18. Cholesterol-lowering agent in men without CHD.
    Millard P; Johnson KH
    J Fam Pract; 1996 Mar; 42(3):223-4. PubMed ID: 8636668
    [No Abstract]   [Full Text] [Related]  

  • 19. [A new study on hypercholesterolemia. Statin is effective against heart disease].
    Olsson AG
    Lakartidningen; 1996 May; 93(22):2131-3. PubMed ID: 8667843
    [No Abstract]   [Full Text] [Related]  

  • 20. Secondary prevention of coronary heart disease: the role of fibric acids.
    Haffner SM
    Circulation; 2000 Jul; 102(1):2-4. PubMed ID: 10880405
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.